Skip to main content

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Psychopharmacology

Medication in hand
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
Patient in counseling
Patient Case Studies: Successful Deprescription of Anticholinergics
Woman taking medication
How Do Emerging Muscarinic Agonists Like KarXT Affect Anticholinergic Use?
Medication in hand
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
Medication
CME: Optimizing the Utility of Muscarinic Acetylcholine Receptor Activators in Clinical Practice
Medication
CME: Interpreting the Latest Clinical Data and Treatment Implications for Approved and Emerging Muscarinic Acetylcholine Receptor Activators in Schizophrenia
Medication
CME: Understanding Muscarinic Acetylcholine Receptor Activation as a Therapeutic Target in Schizophrenia
Medication
CME: Harnessing the Evolving Understanding of Schizophrenia to Address Treatment Challenges and Unmet Needs
Symptoms
Understanding the Cholinergic System
Elder Pt Confused by Medication
Assessing Anticholinergic Burden
Medication
Anticholinergic Misuse: Can These Medications Be Addictive?

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page Next ›
  • Last page Last »
© 2026 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy